Correlation Between Monte Rosa and Immunovant
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Immunovant, you can compare the effects of market volatilities on Monte Rosa and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Immunovant.
Diversification Opportunities for Monte Rosa and Immunovant
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Monte and Immunovant is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Monte Rosa i.e., Monte Rosa and Immunovant go up and down completely randomly.
Pair Corralation between Monte Rosa and Immunovant
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.33 times more return on investment than Immunovant. However, Monte Rosa is 1.33 times more volatile than Immunovant. It trades about 0.05 of its potential returns per unit of risk. Immunovant is currently generating about 0.03 per unit of risk. If you would invest 659.00 in Monte Rosa Therapeutics on September 1, 2024 and sell it today you would earn a total of 377.00 from holding Monte Rosa Therapeutics or generate 57.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Immunovant
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Immunovant |
Monte Rosa and Immunovant Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Immunovant
The main advantage of trading using opposite Monte Rosa and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |